FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
+24.67%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$376M
AUM Growth
+$376M
(+22%)
Cap. Flow
-$1.77M
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Editas Medicine
EDIT
|
$1.77M |
Sector Composition
| 1 | Healthcare | 97.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Seres Therapeutics
MCRB
$166M
| $143M | 37.99% | 12,682,876 | – | – |
|
|
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $76.6M | 20.35% | 4,806,656 | – | – |
|
|
3
Editas Medicine
EDIT
$231M
| $75.4M | 20.03% | 3,376,184 -79,132 | -2% | -$1.77M |
|
4
Agios Pharmaceuticals
AGIO
$2.19B
| $56.4M | 14.98% | 965,369 | – | – |
|
5
Cartesian Therapeutics
RNAC
$261M
| $11.8M | 3.15% | 826,862 | – | – |
|
|
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
| $10.3M | 2.73% | 1,950,583 | – | – |
|
7
Carisma Therapeutics
CARM
$8.98M
| $2.91M | 0.77% | 1,324,018 | – | – |
|